Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Keywords/Phrases:  cholangiocarcinoma
Results 1-25 of 37 for your search:
Start Over
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: PIN-PHO1201, NCI-2014-02418, NCT02082522
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CBGJ398X2204, NCI-2014-01310, 2013-005085-19, NCT02150967
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: PrE0204, NCI-2014-02658, AX-CL-OTHER-PrECOG-004080, NCT02181634
Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NU 08I5, NCI-2009-01122, STU00007062, NCT00858429
Hepatic Arterial Infusion in Treating Patients with Locally Advanced, Non-Metastatic Cholangiocarcinoma
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 201111068, NCI-2011-03785, NCT01525069
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: S4-13-001, NCI-2015-00637, NCT02128282
RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: RRx001-27-01, NCI-2015-00944, NCT02452970
6,8-Bis(benzylthio)octanoic Acid in Treating Patients with Advanced or Metastatic Cholangiocarcinoma that Cannot Be Removed by Surgery
Phase: No phase specified
Type: Treatment
Age: 18 to 80
Trial IDs: CCCWFU 59212, NCI-2013-00063, NCT01766219
Gemcitabine Hydrochloride and Cisplatin with or without Radiation Therapy in Treating Patients with Localized Liver Cancer That Cannot Be Removed by Surgery
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: NRG-GI001, NCI-2014-00849, PNRG-GI001_A01PAMDREVW01, NCT02200042
A Study of LY2801653 in Advanced Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13008, NCI-2013-00662, I3O-MC-JSBA, NCT01285037
Fluorescent Visualization or DNA Analysis in Diagnosing Bile Duct Obstruction in Patients Undergoing Bile Duct Imaging
Phase: No phase specified
Type: Diagnostic
Age: 18 and older
Trial IDs: 201211068, NCI-2013-02250, 13-X110, Cytology 2013, NCT02000999
Floxuridine, Dexamethasone, Gemcitabine Hydrochloride with or without Oxaliplatin in Treating Patients with Liver Cancer That Cannot Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: 13-066, NCI-2013-01067, NCT01862315
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients with Advanced or Metastatic Biliary Cancers
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0524, NCI-2015-00578, NCT02392637
Proton Beam Radiation Therapy and Fluorouracil or Capecitabine in Treating Patients With Upper Gastrointestinal Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 09211, NCI-2011-03312, NCT01449864
Gemcitabine Hydrochloride, Floxuridine, and Dexamethasone after Surgery in Treating Patients with Liver Cancer That Can Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 13-148, NCI-2013-01780, NCT01938729
Evolution® Biliary Stent System-Fully Covered
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 10-014, NCI-2014-02233, NCT02104076
Combination Chemotherapy in Treating Patients With Previously Untreated Locally Advanced or Metastatic Gastrointestinal Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-0033, NCI-2012-00585, 12-0033-AM010, NCT01643499
Regorafenib in Treating Patients With Advanced or Metastatic Biliary Tract Cancer Who Failed First-Line Chemotherapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 13-100, NCI-2014-01117, NCT02053376
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398XUS04, NCI-2014-01999, NCT02160041
ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients with Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 470-12, NCI-2013-00406, NCT01825603
Tremelimumab with Transarterial Chemoembolization, Radiofrequency Ablation, Cryosurgery, or Stereotactic Body Radiation Therapy in Treating Patients with Advanced Liver or Biliary Tract Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-C-0120, NCI-2013-01557, 130120, P121113, NCT01853618
Dasatinib in Treating Patients with Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery and Has an IDH Mutation
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 15-007, NCI-2015-00938, CA180-603, NCT02428855
A Study of PLX8394 as a Single Agent in Patients With Advanced, Unresectable Solid Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: PLX120-03, NCI-2015-00720, NCT02428712
Start Over